Search

Certara Inc

Gesloten

SectorGezondheidszorg

9.08 1.91

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.08

Max

9.19

Belangrijke statistieken

By Trading Economics

Inkomsten

-380K

-9.1M

Verkoop

-14M

93M

K/W

Sectorgemiddelde

100.714

55.725

EPS

0.05

Winstmarge

-9.803

Werknemers

1,515

EBITDA

-4.2M

12M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-11.09% downside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

27M

1.3B

Vorige openingsprijs

7.17

Vorige sluitingsprijs

9.08

Nieuwssentiment

By Acuity

50%

50%

113 / 339 Rangschikking in Healthcare

Certara Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 sep 2026, 20:07 UTC

Certara Inc is advancing, rebounding from an earlier pullback and gaining ground since Thursday's close, amid solid broader market performance.

24 sep 2026, 19:51 UTC

Certara Inc is trading higher, rebounding from an earlier low and maintaining strength above its 20-day moving average during Thursday's session.

23 sep 2026, 20:07 UTC

Certara Inc shares fell sharply after an initial spike, dropping significantly below Tuesday's close despite remaining above its 20-day moving average.

22 sep 2026, 21:01 UTC

Certara Inc is declining in after-market trading, falling sharply below Tuesday's close despite being above its 20-day moving average.

21 sep 2026, 23:25 UTC

Certara Inc is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

18 sep 2026, 20:07 UTC

Certara Inc's stock is declining, having pulled back from an earlier peak, and remains lower compared to Thursday's close while trading above its 20-day moving average.

17 sep 2026, 23:31 UTC

Certara Inc is rising in after-market trading, reaching a peak shortly after the market closed, significantly above its 20-day moving average.

16 sep 2026, 22:01 UTC

Certara Inc is seeing a slight uptick in after-market trading, recovering from a brief dip to achieve a modest gain within its one-month trading range.

15 sep 2026, 20:01 UTC

Certara Inc shares are higher during Tuesday's session, diverging from broader market sentiment impacted by a decline in the NY Empire State Manufacturing Index.

14 sep 2026, 19:51 UTC

Certara Inc shares are trading higher, continuing a recent upward trend. No specific news was identified to explain this price movement.

10 sep 2026, 20:07 UTC

Shares of Certara Inc. are trading lower today, reflecting broader market trends amid five consecutive sessions of declines and pressure from recent interest rate hikes.

9 sep 2026, 20:07 UTC

Certara Inc. shares are lower today, breaking the upward trend seen since Tuesday's close. No specific news or development was identified.

8 sep 2026, 19:41 UTC

Certara Inc is lower today, impacted by weakness in the Health Care Technology sub-sector. The stock remains below its 20-day moving average.

3 sep 2026, 20:07 UTC

Certara Inc shares are lower today, continuing a decline since Wednesday amid a broader downturn in the health care technology sector.

1 sep 2026, 20:08 UTC

Certara Inc shares are lower today, continuing a downward trend from earlier sessions and remaining below the 20-day moving average.

31 aug 2026, 22:02 UTC

Shares of Certara Inc. are trading lower during after-market hours, reversing a trend of higher daily closes. No specific news was identified.

27 aug 2026, 20:01 UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

26 aug 2026, 19:56 UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

25 aug 2026, 20:51 UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

24 aug 2026, 20:01 UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

21 aug 2026, 19:56 UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

20 aug 2026, 20:06 UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

19 aug 2026, 23:56 UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

18 aug 2026, 19:36 UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

13 aug 2026, 19:41 UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

12 aug 2026, 19:46 UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

11 aug 2026, 23:51 UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

7 aug 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 aug 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 aug 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

Peer Vergelijking

Prijswijziging

Certara Inc Prognose

Koersdoel

By TipRanks

-11.09% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.1 USD  -11.09%

Hoogste 9 USD

Laagste 7 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Certara Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

7 ratings

1

Buy

6

Hold

0

Sell

Sentiment

By Acuity

113 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.